Woźniak, M.; Borkowska, A.; Jastrzębska, M.; Sochal, M.; Małecka-Wojciesko, E.; Talar-Wojnarowska, R.
Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease. Metabolites 2023, 13, 1006.
https://doi.org/10.3390/metabo13091006
AMA Style
Woźniak M, Borkowska A, Jastrzębska M, Sochal M, Małecka-Wojciesko E, Talar-Wojnarowska R.
Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease. Metabolites. 2023; 13(9):1006.
https://doi.org/10.3390/metabo13091006
Chicago/Turabian Style
Woźniak, Małgorzata, Anna Borkowska, Marta Jastrzębska, Marcin Sochal, Ewa Małecka-Wojciesko, and Renata Talar-Wojnarowska.
2023. "Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease" Metabolites 13, no. 9: 1006.
https://doi.org/10.3390/metabo13091006
APA Style
Woźniak, M., Borkowska, A., Jastrzębska, M., Sochal, M., Małecka-Wojciesko, E., & Talar-Wojnarowska, R.
(2023). Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease. Metabolites, 13(9), 1006.
https://doi.org/10.3390/metabo13091006
